LYRA vs UHS · rev $1.5M vs P/E 5.9, rev $9.13B
Lyra Therapeutics Inc (LYRA) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
LYRA currently screens at market cap $14.4M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the LYRA and UHS stock pages for the full models.
Not investment advice.